149 related articles for article (PubMed ID: 25174263)
1. The impact of tumour size on the probability of synchronous metastasis and survival in renal cell carcinoma patients: a population-based study.
Ingimarsson JP; Sigurdsson MI; Hardarson S; Petursdottir V; Jonsson E; Einarsson GV; Gudbjartsson T
BMC Urol; 2014 Aug; 14():72. PubMed ID: 25174263
[TBL] [Abstract][Full Text] [Related]
2. [Pulmonary resections for metastatic renal cell carcinoma in Iceland].
Oddsson SJ; Isaksson HJ; Jonsson E; Einarsson GV; Gudbjartsson T
Laeknabladid; 2008 May; 94(5):377-81. PubMed ID: 18460734
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
[TBL] [Abstract][Full Text] [Related]
4. [Small renal cell carcinomas and synchronous metastases].
Gudjonsson PS; Mariusdottir E; Palsdottir HB; Einarsson GV; Jonsson E; Petursdottir V; Hardarson S; Sigurdsson MI; Gudbjartsson T
Laeknabladid; 2012 Nov; 98(11):585-9. PubMed ID: 23232659
[TBL] [Abstract][Full Text] [Related]
5. Outcomes following partial nephrectomy by tumor size.
Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience.
Klatte T; Patard JJ; Goel RH; Kleid MD; Guille F; Lobel B; Abbou CC; De La Taille A; Tostain J; Cindolo L; Altieri V; Ficarra V; Artibani W; Prayer-Galetti T; Allhoff EP; Schips L; Zigeuner R; Figlin RA; Kabbinavar FF; Pantuck AJ; Belldegrun AS; Lam JS
J Urol; 2007 Jul; 178(1):35-40; discussion 40. PubMed ID: 17521678
[TBL] [Abstract][Full Text] [Related]
7. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.
Tsui KH; Shvarts O; Smith RB; Figlin RA; deKernion JB; Belldegrun A
J Urol; 2000 Apr; 163(4):1090-5; quiz 1295. PubMed ID: 10737472
[TBL] [Abstract][Full Text] [Related]
8. Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population.
Breda A; Lucarelli G; Rodriguez-Faba O; Guirado L; Facundo C; Bettocchi C; Gesualdo L; Castellano G; Grandaliano G; Battaglia M; Palou J; Ditonno P; Villavicencio H
World J Urol; 2015 Jan; 33(1):1-7. PubMed ID: 24504760
[TBL] [Abstract][Full Text] [Related]
9. Impact of tumor size on the long-term survival of patients with early stage renal cell cancer.
Kuczyk M; Wegener G; Merseburger AS; Anastasiadis A; Machtens S; Zumbrägel A; Hartmann JT; Bokemeyer C; Jonas U; Stenzl A
World J Urol; 2005 Feb; 23(1):50-4. PubMed ID: 15729558
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
Yoo C; Song C; Hong JH; Kim CS; Ahn H
J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
[TBL] [Abstract][Full Text] [Related]
11. The critical impact of tumor size in predicting cancer special survival for T3aM0M0 renal cell carcinoma: A proposal of an alternative T3aN0M0 stage.
Li L; Shi L; Zhang J; Fan Y; Li Q
Cancer Med; 2021 Jan; 10(2):605-614. PubMed ID: 33280246
[TBL] [Abstract][Full Text] [Related]
12. Risk of metastasis for T1a renal cell carcinoma.
Lee H; Lee JK; Kim K; Kwak C; Kim HH; Byun SS; Lee SE; Hong SK
World J Urol; 2016 Apr; 34(4):553-9. PubMed ID: 26245747
[TBL] [Abstract][Full Text] [Related]
13. Impact of tumor size on patient survival after radical nephrectomy for pathological T3a renal cell carcinoma.
Sugiyama Y; Yatsuda J; Murakami Y; Ito N; Yamasaki T; Mikami Y; Ogawa O; Kamba T
Jpn J Clin Oncol; 2019 May; 49(5):465-472. PubMed ID: 30793163
[TBL] [Abstract][Full Text] [Related]
14. Operative mortality after nephrectomy for renal cell carcinoma.
Thoroddsen A; Gudbjartsson T; Jonsson E; Gislason T; Einarsson GV
Scand J Urol Nephrol; 2003; 37(6):507-11. PubMed ID: 14675926
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
[TBL] [Abstract][Full Text] [Related]
16. Metastatic potential of a renal mass according to original tumour size at presentation.
Umbreit EC; Shimko MS; Childs MA; Lohse CM; Cheville JC; Leibovich BC; Blute ML; Thompson RH
BJU Int; 2012 Jan; 109(2):190-4; discussion 194. PubMed ID: 21557795
[TBL] [Abstract][Full Text] [Related]
17. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease.
Blute ML; Amling CL; Bryant SC; Zincke H
Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850
[TBL] [Abstract][Full Text] [Related]
18. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.
Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV
Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127
[TBL] [Abstract][Full Text] [Related]
19. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas.
Klatte T; Patard JJ; de Martino M; Bensalah K; Verhoest G; de la Taille A; Abbou CC; Allhoff EP; Carrieri G; Riggs SB; Kabbinavar FF; Belldegrun AS; Pantuck AJ
J Urol; 2008 May; 179(5):1719-26. PubMed ID: 18343437
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system.
Belldegrun A; Tsui KH; deKernion JB; Smith RB
J Clin Oncol; 1999 Sep; 17(9):2868-75. PubMed ID: 10561364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]